Dylan Morris

Dylan Morris currently serves as a Managing Director at Insight Partners since 2021 and holds multiple Board Director positions at Exsilio Therapeutics, Superluminal Medicines Inc., ImmuneBridge, Profluent Bio, Unlearn.AI, Gameto, Capacity Bio, DEM Biopharma, Inc., and ArrePath from 2022 onwards. Dylan holds a degree in Computer Science from Harvard University and has completed Graduate Research in Biochemistry and Molecular Biophysics at Caltech.